Caption Management, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,615,000
+404.7%
50,000
+316.7%
0.02%
+375.0%
Q3 2021$320,000
-78.1%
12,000
-79.3%
0.00%
-87.9%
Q4 2020$1,459,000
+114.2%
58,000
+199.0%
0.03%
-13.2%
Q1 2019$681,000
-80.3%
19,400
-81.3%
0.04%
-86.2%
Q4 2018$3,456,000104,0000.28%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders